These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 37163829)
41. Screening ultrasonography revealed 15% of mammographically occult breast cancers. Uchida K; Yamashita A; Kawase K; Kamiya K Breast Cancer; 2008; 15(2):165-8. PubMed ID: 18224382 [TBL] [Abstract][Full Text] [Related]
42. Magnetic Resonance Imaging in the Pre-Surgical Staging of Breast Cancer: Our Experience. Rabasco P; Caivano R; Dinardo G; Gioioso M; Lotumolo A; Iannelli G; Villonio A; La Torre G; D'Errico S; Macarini L; Guglielmi G; Cammarota A Cancer Invest; 2017 Jan; 35(1):43-50. PubMed ID: 27901596 [TBL] [Abstract][Full Text] [Related]
43. Active surveillance of women diagnosed with atypical ductal hyperplasia on core needle biopsy may spare many women potentially unnecessary surgery, but at the risk of undertreatment for a minority: 10-year surgical outcomes of 114 consecutive cases from a single center. Farshid G; Edwards S; Kollias J; Gill PG Mod Pathol; 2018 Mar; 31(3):395-405. PubMed ID: 29099502 [TBL] [Abstract][Full Text] [Related]
44. The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI. Vreemann S; van Zelst JCM; Schlooz-Vries M; Bult P; Hoogerbrugge N; Karssemeijer N; Gubern-Mérida A; Mann RM Breast Cancer Res; 2018 Aug; 20(1):84. PubMed ID: 30075794 [TBL] [Abstract][Full Text] [Related]
45. Identifying Women at Risk for Hereditary Breast and Ovarian Cancer Syndrome Utilizing Breast Care Nurse Navigation at Mammography and Imaging Centers. Appel SJ; Cleiment RJ J Natl Black Nurses Assoc; 2015 Dec; 26(2):17-26. PubMed ID: 27045154 [TBL] [Abstract][Full Text] [Related]
46. Role of MRI in breast cancer management. Enriquez L; Listinsky J Cleve Clin J Med; 2009 Sep; 76(9):525-32. PubMed ID: 19726557 [TBL] [Abstract][Full Text] [Related]
47. A preliminary report of breast cancer screening by positron emission mammography. Yamamoto Y; Tasaki Y; Kuwada Y; Ozawa Y; Inoue T Ann Nucl Med; 2016 Feb; 30(2):130-7. PubMed ID: 26586370 [TBL] [Abstract][Full Text] [Related]
48. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501 [TBL] [Abstract][Full Text] [Related]
49. Characteristics of Invasive Breast Cancer Detected by Digital Breast Tomosynthesis on Screening and Diagnostic Mammograms. Baydoun SE; Yang L; Xiong J; Fajardo LL Can Assoc Radiol J; 2021 May; 72(2):242-250. PubMed ID: 32062995 [TBL] [Abstract][Full Text] [Related]
50. Screening mammography: value in women 35-39 years old. Liberman L; Dershaw DD; Deutch BM; Thaler HT; Lippin BS AJR Am J Roentgenol; 1993 Jul; 161(1):53-6. PubMed ID: 8517320 [TBL] [Abstract][Full Text] [Related]
51. Retrospective and comparative analysis of (99m)Tc-Sestamibi breast specific gamma imaging versus mammography, ultrasound, and magnetic resonance imaging for the detection of breast cancer in Chinese women. Yu X; Hu G; Zhang Z; Qiu F; Shao X; Wang X; Zhan H; Chen Y; Deng Y; Huang J BMC Cancer; 2016 Jul; 16():450. PubMed ID: 27401536 [TBL] [Abstract][Full Text] [Related]
52. [New trends and novel possibilities in the diagnostic imaging of breast cancer]. Bidlek M; Kovács E; Fehér K; Gõdény M Magy Onkol; 2015 Mar; 59(1):44-55. PubMed ID: 25763913 [TBL] [Abstract][Full Text] [Related]
53. Multimodality screening of high-risk women: a prospective cohort study. Weinstein SP; Localio AR; Conant EF; Rosen M; Thomas KM; Schnall MD J Clin Oncol; 2009 Dec; 27(36):6124-8. PubMed ID: 19884532 [TBL] [Abstract][Full Text] [Related]
54. Neglecting to screen women between the ages of 40 and 49 years with mammography: what is the impact on breast cancer diagnosis? Kremer ME; Downs-Holmes C; Novak RD; Lyons JA; Silverman P; Pham RM; Plecha DM AJR Am J Roentgenol; 2012 May; 198(5):1218-22. PubMed ID: 22528917 [TBL] [Abstract][Full Text] [Related]
55. MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial. Saadatmand S; Geuzinge HA; Rutgers EJT; Mann RM; de Roy van Zuidewijn DBW; Zonderland HM; Tollenaar RAEM; Lobbes MBI; Ausems MGEM; van 't Riet M; Hooning MJ; Mares-Engelberts I; Luiten EJT; Heijnsdijk EAM; Verhoef C; Karssemeijer N; Oosterwijk JC; Obdeijn IM; de Koning HJ; Tilanus-Linthorst MMA; Lancet Oncol; 2019 Aug; 20(8):1136-1147. PubMed ID: 31221620 [TBL] [Abstract][Full Text] [Related]
56. Application of the downgrade criteria to supplemental screening ultrasound for women with negative mammography but dense breasts. Kim SY; Kim MJ; Moon HJ; Yoon JH; Kim EK Medicine (Baltimore); 2016 Nov; 95(44):e5279. PubMed ID: 27858896 [TBL] [Abstract][Full Text] [Related]
57. Dynamic contrast enhanced magnetic resonance imaging of the breast is superior to triple assessment for the pre-operative detection of multifocal breast cancer. Drew PJ; Chatterjee S; Turnbull LW; Read J; Carleton PJ; Fox JN; Monson JR; Kerin MJ Ann Surg Oncol; 1999 Sep; 6(6):599-603. PubMed ID: 10493630 [TBL] [Abstract][Full Text] [Related]
58. The role of sonography in patients with breast cancer presenting as an axillary mass. Park SY; Kim EK; Oh KK; Lee KS; Park BW Korean J Radiol; 2002; 3(3):189-93. PubMed ID: 12271164 [TBL] [Abstract][Full Text] [Related]
59. Mammographic, US, and MR imaging phenotypes of familial breast cancer. Schrading S; Kuhl CK Radiology; 2008 Jan; 246(1):58-70. PubMed ID: 18096529 [TBL] [Abstract][Full Text] [Related]
60. Impact of breast MRI in women eligible for breast conservation surgery and intra-operative radiation therapy. Paudel N; Bethke KP; Wang LC; Strauss JB; Hayes JP; Donnelly ED Surg Oncol; 2018 Mar; 27(1):95-99. PubMed ID: 29549911 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]